BioNTech, Roche Scrap Cancer Vaccine Trial in Blow to New Field

bloomberg

·

Original Report

↗ bloomberg

BioNTech SE and Roche Holding AG abandoned a trial of a personalized cancer vaccine, dashing hopes that had been raised by a rival drugmaker’s recent success in the same field.